Beone Medicines Ltd (ONC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 1,498,170 | 1,412,284 | 1,315,300 | 1,117,279 | 1,127,824 |
| Cost of Goods | 142,422 | 196,510 | 164,606 | 165,002 | 160,560 |
| Gross Profit | 1,355,748 | 1,215,774 | 1,150,694 | 952,277 | 967,264 |
| Operating Expenses | 1,171,135 | 1,053,170 | 1,063,415 | 941,177 | 1,047,249 |
| Operating Income | 185,035 | 163,114 | 87,885 | 11,102 | -79,425 |
| Other Income | -35,794 | -15,950 | 11,664 | 9,798 | -5,926 |
| Pre-tax Income | 149,241 | 147,164 | 99,549 | 20,900 | -85,351 |
| Income Tax | 82,739 | 22,323 | 5,229 | 19,630 | 66,530 |
| Net Income Continuous | 66,502 | 124,841 | 94,320 | 1,270 | -151,881 |
| Net Income | $66,502 | $124,841 | $94,320 | $1,270 | $-151,881 |
| EPS Basic Total Ops | 0.62 | 1.13 | 0.87 | 0.01 | -1.41 |
| EPS Basic Continuous Ops | 0.62 | 1.13 | 0.87 | 0.01 | -1.42 |
| EPS Diluted Total Ops | 0.59 | 1.09 | 0.84 | 0.01 | -1.41 |
| EPS Diluted Continuous Ops | 0.59 | 1.09 | 0.84 | 0.01 | -1.42 |
| EPS Diluted Before Non-Recurring Items | 0.58 | 1.09 | 0.84 | 1.22 | -1.43 |
| EBITDA(a) | $221,019 | $200,398 | $123,499 | $43,906 | $-29,179 |